Phase 2 Randomized Study Comparing Two Dose Schedules of Ezatiostat Hydrochloride (Telintra, TLK199 Tablets) in Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS).
Phase of Trial: Phase II
Latest Information Update: 13 Dec 2011
At a glance
- Drugs Ezatiostat (Primary)
- Indications Myelodysplastic syndromes
- Focus Therapeutic Use
- Sponsors Telik
- 13 Dec 2011 Results presented at the 53rd Annual Meeting and Exposition of the American Society of Hematology, according to a Telik media release.
- 29 Sep 2011 Results publised online in Cancer.
- 01 Sep 2011 Results published in the Cancer.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History